Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitro-Dur patches for peripheral arterial disease of the feet
ACTRN12612000883819Phase 3Recruiting
- Sponsor
- Charles Sturt University
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of nitroglycerin in arteriosclerosis obliterans (4 arms), sponsored by Charles Sturt University. Primary endpoints: Vascular toe pressure at the hallux and Pain experience. Started Jan 2012; status: recruiting.
02
Drugs
nitroglycerin
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on ACTRN12612000883819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000883819.